Search

everythinglearnresearchcommunity

for

Search:↓

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

Skin organoids can mimic human skin responses to injury and inflammation, making them useful for studying skin diseases and testing treatments.

Enhancing antioxidant responses can improve treatments for various diseases.

Rat hair follicle stem cells can be used to improve blood vessel growth in engineered skin.

Autophagy is essential for proper skin cell development and function.

Abnormal ECM and immune cell interactions can cause skin diseases.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

JAK inhibitors may reverse early hair loss, but prolonged inflammation can cause permanent hair loss.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

Activin A and follistatin control when ear hair cells form in mice.

Hair follicles prevent NK cell attacks to avoid hair loss.

Smart microneedles can deliver drugs painlessly and accurately for diseases like diabetes and tumors.

COVID-19 may trigger alopecia areata, but more research is needed.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

PPAR activation can improve diabetic wound healing by enhancing blood vessel function.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Biomaterials can improve non-viral gene delivery by enhancing DNA uptake and reducing toxicity.